Clinical Trials on Non-Myeloid Malignancies
Total 26856 results
-
AmgenCompletedCancer | Non-Myeloid Malignancies
-
AmgenCompleted
-
AmgenCompletedAnemia | Non-Myeloid Malignancies
-
AmgenCompletedAnemia | Non-Myeloid Malignancies
-
AmgenCompletedAnemia | Non-Myeloid Malignancies
-
AmgenCompletedCancer | Anemia | Non-Myeloid Malignancies
-
Shenyang Sunshine Pharmaceutical Co., LTD.Not yet recruitingChemotherapy-induced Anemia | Non-myeloid Malignancies
-
Pharmacosmos A/SCompletedNon-myeloid Malignancies | Chemotherapy Induced AnaemiaIndia
-
Sichuan UniversityRecruitingMyeloid MalignanciesChina
-
Southwest Hospital, ChinaUnknown
-
M.D. Anderson Cancer CenterRecruitingMyeloid MalignanciesUnited States
-
Gilead SciencesTerminatedMyeloid MalignanciesUnited States, Australia, United Kingdom
-
Southwest Hospital, ChinaUnknown
-
AmgenCompletedCancer | Anemia | Non-Myeloid Malignancies
-
Cristina GasparettoAgilent Technologies, Inc.Active, not recruitingLymphoid Malignancies | Myeloid MalignanciesUnited States
-
M.D. Anderson Cancer CenterRecruitingMyeloid Malignancies | Lymphodepleting ChemotherapyUnited States
-
Tongji HospitalHebei Taihe Chunyu Biotechnology Co., LtdNot yet recruitingCAR-T | Myeloid MalignanciesChina
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
AmgenTerminatedNeoplasms | Carcinoma | Cancer | Anemia | Non-Myeloid Malignancies | Anemia of Cancer
-
M.D. Anderson Cancer CenterNot yet recruiting
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Japan
-
Catherine BollardJohns Hopkins University; Children's National Research InstituteRecruitingRelapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDSUnited States
-
ExCellThera inc.Memorial Sloan Kettering Cancer CenterRecruitingCord Blood Transplant | High Risk Myeloid MalignanciesUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedChildhood Acute Myeloid Leukemia/Other Myeloid MalignanciesUnited States
-
iCell Gene TherapeuticsiCar Bio TherapeuticsNot yet recruitingHigh Risk Hematologic Malignancies | Relapsed and/or Refractory Acute Myeloid LeukemiaChina
-
Otsuka Pharmaceutical Co., Ltd.CompletedAcute Myeloid Leukemia | Multiple Myeloma | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia | Acute Lymphoid LeukemiaJapan
-
Caribou Biosciences, Inc.Enrolling by invitationLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Hematologic Malignancy | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin's LymphomaUnited States
-
Gruppo Italiano Trapianto di Midollo OsseoCompleted
-
Novartis PharmaceuticalsTerminatedAcute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Non-Hodgkin Lymphoma (NHL)Belgium, Italy, Korea, Republic of, Hong Kong, Israel, Finland, Spain, Japan, United States
-
Gilead SciencesCompletedChronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Multiple Myeloma (MM) | Lymphoma, Non-Hodgkin (NHL)United States
-
Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of MedicineCompletedMyeloid Hematological MalignanciesUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Novartis... and other collaboratorsTerminated
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Non-hematologic MalignanciesUnited States, Canada
-
PfizerCompletedAdvanced Non-Hematologic MalignanciesUnited Kingdom
-
Novartis PharmaceuticalsCompletedNON-breast HER2+ MalignanciesUnited States, Italy, Korea, Republic of, Japan
-
PfizerTerminatedAdvanced Non-Hematologic MalignanciesUnited States, United Kingdom
-
University of Illinois at ChicagoCompletedIntensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies (IM-TMI)Acute Myeloid Leukemia | Chronic Myeloid Leukemia | Acute Leukemia | Lymphoblastic Leukemia | Non Hodgkins LymphomaUnited States
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
AbbVieGenentech, Inc.; AmgenTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States, Australia, Germany
-
AmgenTerminatedAcute Myeloid Leukemia | Multiple Myeloma | AML | Myelodysplastic Syndrome | MDS | Non-Hodgkins Lymphoma | NHLUnited States, Australia, Italy, France, Greece, Japan
-
Institut de Recherches Internationales ServierRecruitingMyelodysplastic Syndromes | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Untreated AML | Other IDH1-mutated Positive Hematologic MalignanciesUnited States, France
-
St. Jude Children's Research HospitalOhio State University; Arog Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.TerminatedNon-hematologic Malignancies | Pharmacokinetics of ASP9853United States
-
SanofiRecruitingAcute Myeloid LeukemiaAustralia, United States
-
Erasca, Inc.WithdrawnAcute Myeloid LeukemiaUnited States
-
AmgenCompletedLeukemia | Myeloid Leukemia | Cancer | Hematologic MalignanciesUnited States
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingAcute Myeloid Leukemia | Multiple Myeloma | Non-hodgkin's LymphomaChina
-
AvenCell Europe GmbHAllucent (NL) BVRecruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryGermany, Netherlands
-
Gilead SciencesTerminatedAcute Myeloid Leukemia | Hematologic MalignancyJapan